|
levitra vardenafil:
|
levitra vardenafil D on the Erectile Function (EF) Domain score of the validated International Index of Erectile Function (IIEF) Questionnaire and two questions from the Sexual Encounter Profile (SEP) corresponding to vaginal penetration achievement (SEP2) levitra vardenafil, and the ability to maintain an erection for intercourse (SEP3). Results demonstrated clinically meaningful and statistically significant improvements in the EF Domain levitra vardenafil, SEP2 levitra vardenafil, and SEP3 scores compared to placebo. The mean baseline EF Domain score in these trials was 11.8. In a major North American fixed dose trial levitra vardenafil, 762 subjects were evaluated. The mean baseline EF Domain scores were 13 levitra vardenafil, 13 levitra vardenafil, 13 levitra vardenafil, 14 for the Levitra 5 mg levitra vardenafil, 10 mg levitra vardenafil, levitra vardenafil.
levitra vardenafil 20 mg and placebo groups levitra vardenafil, respectively. There was significant improvement at three months with Levitra (EF Domain scores of 18 levitra vardenafil, 21 levitra vardenafil, 21 levitra vardenafil, for the 5 mg levitra vardenafil, 10 mg and 20 mg dose groups levitra vardenafil, respectively) compared to the placebo group (EF Domain score of 15). The European trial of 803 subjects confirmed these results. In the North American trial levitra vardenafil, Levitra significantly improved the rates of achieving an erection sufficient for penetration (SEP2) at doses of 5 mg levitra vardenafil, 10 mg levitra vardenafil, and 20 mg compared to placebo (65% levitra vardenafil, 75% levitra vardenafil, and 80% levitra vardenafil, respectively levitra vardenafil, compared to a 52% response in the placebo at 3 months. The European trial confirmed these results. Side Effects Adverse events associated with the use of Levitra may include (but are not limited to) the following: Headache Flushing Rhinitis Dyspepsia Accidental Injury Sinusitis Flu Syndrome Dizziness Nausea Mechanism of Action Levitra is a selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5). Erection of the penis is initiated by the relaxation of smooth muscle in the corpus cavernosum levitra vardenafil, one of a pair of sponge-like regions in the penis. When aroused levitra vardenafil, nitric oxide is released from nerve endings and endothelial cells in the corpus cavernosum. Nitric oxide activates the enzyme guanylate cyclase resulting in increased synthesis of cyclic guanosine mon.
levitra vardenafil Th the use of Levitra may include (but are not limited to) the following: Headache Flushing Rhinitis Dyspepsia Accidental Injury Sinusitis Flu Syndrome Dizziness Nausea Mechanism of Action Levitra is a selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5). Erection of the penis is initiated by the relaxation of smooth muscle in the corpus cavernosum levitra vardenafil, one of a pair of sponge-like regions in the penis. When aroused levitra vardenafil, nitric oxide is released from nerve endings and endothelial cells in the corpus cavernosum. Nitric oxide activates the enzyme guanylate cyclase resulting in increased synthesis of cyclic guanosine mono.
levitra vardenafil 
levitra vardenafil | | | | | |
levitra vardenafil
|
|
Der, chemical name, inactive"> Vardenafil HCl Get RxList-trusted information when you Google! Learn more body .list-item & 8226; Company Issues Pacemaker Malfunction Warning & 8226; Deaths Seen With Fentanyl Narcotic Pain Patch & 8226; FDA Reviews Adult Antidepressant-Suicide Link LEVITRA& 210; (vardenafil HCl) TABLETS DESCRIPTION LEVITRA& 210; is an oral therapy for the treatment of erectile dysfunction. This monohydrochloride salt of vardenafil is a selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5). Vardenafil HCl is designated chemically as piperazine, 1- 3-(1,4-dihydro-5-methyl-4-oxo-7-propylimidazo 5,1-f 1,2,4 triazin-2-yl)-4-ethoxyphenyl sulfonyl -4-ethyl-, monohydrochloride and has the following structural formula: Vardenafil HCl is a nearly colorless, solid substance with a molecular weight of 579.1 g mol and a solubility of 0.11 mg mL in water. LEVITRA is formulated as orange, round, film-coated tablets with "BAYER" cross debossed on one side and "2.5", "5", "10", and "20" on the other side corresponding to 2.5 mg, 5 mg, 10 mg, and 20 mg of vardenafil, respectively. In addition to the active ingredient, vardenafil HCl, each tablet contains microcrystalline cellulose, crospovidone, colloidal silicon dioxide, magnesium stearate, hypromellose, polyethylene glycol, titanium dioxide, yellow ferric oxide, and red ferric oxide. For information on ordering Levitra Online, please click the "online pharmacy" link on the blue horizontal navigation bar at the top of every page
|
|
